For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human NBL1 aa 100 to the C-terminus (Cysteine residue). The exact sequence is proprietary.
Database link: P41271
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab174843 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||1/100 - 1/250.|
|Flow Cyt||1/10 - 1/100.
ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
|WB||1/1000 - 1/5000. Detects a band of approximately 23 kDa (predicted molecular weight: 19 kDa).|
Immunofluorescent analysis of A431 cells labeling NBL1 with ab174827 at 1/100 dilution (red). DAPI nuclear staining (blue).
Flow cytometric analysis of permeabilized A431 cells labeling NBL1 with ab174843 at 1/10 dilution (red), or negative control rabbit IgG (green).
ab174843 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"